MetaCap

Haemonetics Statistics

NYSE: HAEHealth CareMedical/Dental InstrumentsUSD

101.71-1.81 (-1.75%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Haemonetics by the numbers

Haemonetics has a market capitalization of $4.63 billion based on 45.50M shares outstanding. Its trailing P/E ratio is 49.1, above the 4-company peer median of 37.4, and its forward P/E is 17.6. The stock trades 1.8% above its 50-day average and 35.1% above its 200-day average.

Average daily trading volume is 679.79K shares, or about $69.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

HAE valuation vs. peer median

HAE compared with the median of 8 peer companies
MetricHAEPeer medianDifference
Market cap$4.63B$4.69B-1%
P/E (TTM)49.137.4+31%
Forward P/E17.617.3+2%
Avg. volume679.79K724.51K-6%

Peer median across 8 companies: MMSI, HTFL, TFX, STVN, MMED, ICUI, NVST, PLSE.

Valuation

Price / sales (latest FY)
3.47

Price and trading

Previous close
103.52
Open
103.48
Day range
101.33 – 104.02
52-week range
48.17 – 110.45
52-week change
+106.48%
Beta
—
Volume
614.47K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
4.63B
Pe
49.14
Forward Pe
17.61
Eps
2.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
110.45
Week52 Low
48.17
Avg Volume
679.79K
Shares Outstanding
45.50M
Ma50
99.87
Ma200
75.26
Earnings Date
Nov 5, 2026
Pct From52w High
-7.91%
Pct From52w Low
111.15%

Related